3.28
price down icon2.96%   -0.10
after-market アフターアワーズ: 3.28
loading
前日終値:
$3.38
開ける:
$3.34
24時間の取引高:
251.21K
Relative Volume:
0.65
時価総額:
$162.82M
収益:
$230.47M
当期純損益:
$30.28M
株価収益率:
5.377
EPS:
0.61
ネットキャッシュフロー:
$38.86M
1週間 パフォーマンス:
+1.39%
1か月 パフォーマンス:
+7.89%
6か月 パフォーマンス:
-3.24%
1年 パフォーマンス:
-13.91%
1日の値動き範囲:
Value
$3.255
$3.355
1週間の範囲:
Value
$3.255
$3.45
52週間の値動き範囲:
Value
$2.225
$4.13

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name
名前
Puma Biotechnology Inc
Name
セクター
Healthcare (1170)
Name
電話
(424) 248-6500
Name
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
Name
職員
172
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PBYI's Discussions on Twitter

PBYI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PBYI
Puma Biotechnology Inc
3.28 160.58M 230.47M 30.28M 38.86M 0.61
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-28 アップグレード Citigroup Neutral → Buy
2020-06-25 再開されました BofA/Merrill Underperform
2019-10-08 ダウングレード Goldman Neutral → Sell
2019-05-10 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-05-10 ダウングレード Citigroup Buy → Neutral
2019-01-17 開始されました Leerink Partners Mkt Perform
2019-01-03 ダウングレード Guggenheim Buy → Neutral
2018-11-19 アップグレード Goldman Sell → Neutral
2018-11-02 ダウングレード BofA/Merrill Buy → Underperform
2018-11-02 ダウングレード JP Morgan Neutral → Underweight
2018-10-01 開始されました Cantor Fitzgerald Overweight
2018-09-17 開始されました Goldman Sell
2018-05-11 繰り返されました Stifel Buy
2017-11-10 繰り返されました Citigroup Buy
2017-11-10 繰り返されました RBC Capital Mkts Sector Perform
2017-10-02 繰り返されました Stifel Buy
2017-09-11 繰り返されました Credit Suisse Outperform
2017-07-10 再開されました Leerink Partners Outperform
2017-06-06 繰り返されました RBC Capital Mkts Sector Perform
2017-05-25 繰り返されました RBC Capital Mkts Sector Perform
2017-03-02 繰り返されました RBC Capital Mkts Sector Perform
すべてを表示

Puma Biotechnology Inc (PBYI) 最新ニュース

pulisher
May 28, 2025

Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors - sharewise

May 28, 2025
pulisher
May 26, 2025

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? - Yahoo Finance

May 26, 2025
pulisher
May 20, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Fly 25% But Investors Aren't Buying For Growth - simplywall.st

May 20, 2025
pulisher
May 17, 2025

Is Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Puma Biotechnology Inc (PBYI) Forecast: Revisiting The Past To Gain Insights For The Future - Stocksregister

May 17, 2025
pulisher
May 15, 2025

Puma Biotechnology's (NASDAQ:PBYI) Earnings Are Of Questionable Quality - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Puma Biotechnology targets $192M-$198M NERLYNX revenue for 2025 amid strategic efforts - MSN

May 14, 2025
pulisher
May 14, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Bought by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 12, 2025

Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock - Nasdaq

May 12, 2025
pulisher
May 12, 2025

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - MSN

May 12, 2025
pulisher
May 10, 2025

Puma Biotechnology First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 10, 2025
pulisher
May 10, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Puma Biotech CCO Jeff Ludwig departs, no replacement named By Investing.com - Investing.com Canada

May 10, 2025
pulisher
May 10, 2025

Puma Biotech CCO Jeff Ludwig departs, no replacement named - Investing.com

May 10, 2025
pulisher
May 09, 2025

Puma Biotechnology, Inc. Announces Termination of Jeff J. Ludwig as Chief Commercial Officer - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Terminates Chief Commercial Officer - TipRanks

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Puma Biotechnology Reports Positive Q1 2025 Earnings - TipRanks

May 09, 2025
pulisher
May 08, 2025

Puma Biotech Q1 2025 slides: NERLYNX revenue up 7% YoY despite quarterly decline - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Puma Biotech: Q1 Earnings Snapshot - The Washington Post

May 08, 2025
pulisher
May 08, 2025

Cautious Hold Rating on Puma Biotechnology Amid Declining Sales and Uncertain Trial Outcomes - TipRanks

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Puma Biotech Q1 2025 results miss forecasts By Investing.com - Investing.com UK

May 08, 2025
pulisher
May 08, 2025

Puma Biotechnology Reports First Quarter Financial Results - BioSpace

May 08, 2025
pulisher
May 08, 2025

Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Puma Biotech Q1 2025 results miss forecasts - Investing.com

May 08, 2025
pulisher
May 07, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)May 6, 2025 - BioSpace

May 07, 2025
pulisher
May 01, 2025

Check out these key findings about Puma Biotechnology Inc (PBYI) - Sete News

May 01, 2025
pulisher
Apr 30, 2025

Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Er-Kim Announces Exclusive Distribution Agreement with Puma - GlobeNewswire

Apr 30, 2025
pulisher
Apr 28, 2025

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Yahoo Finance

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - BioSpace

Apr 25, 2025
pulisher
Apr 23, 2025

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why - MSN

Apr 22, 2025
pulisher
Apr 21, 2025

Is The Options Market Predicting A Spike In Puma Biotechnology Stock? - Barchart.com

Apr 21, 2025
pulisher
Apr 21, 2025

Is the Options Market Predicting a Spike in Puma Biotechnology Stock? - Yahoo Finance

Apr 21, 2025
pulisher
Apr 11, 2025

Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential - Seeking Alpha

Apr 11, 2025

Puma Biotechnology Inc (PBYI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):